Volume 42
Issue 4, 2019
ISSX President’s Message By Thomas Baillie, ISSX President This President’s Message, appearing as it does in the final issue of the ISSX Newsletter for 2019, is my last as President of the Society since my two-year term expires at the end of December. Professor Ann Daly from the University of Newcastle in England will succeed me in the role of ISSX President for 2020–2021. I extend a warm welcome to her in this new position. Many of you know Ann from her extensive research in the area of drug pharmacogenetics, a field in which she is an internationally recognized exper t and from her long and active involvement with ISSX through our meetings, conference organization, and Society leadership. With suppor t from the newly elected and returning members of Council, the future of ISSX in the next two years is in good hands, indeed! Looking back, ISSX had a ver y successful year in 2019, the premier event being the 12th
International ISSX Meeting in Por tland, OR during late July. According to Society policy, only one meeting is held ever y third year when the international meeting takes place, as was the case in 2019. However, based on the success of our past workshops, we aim to hold workshops focused on specific topics on a regular basis, and we look for ward to the upcoming workshop, “Disposition of Biologics,” organized jointly by Dhaval Shah and Honghui Zhou, at the Merck facility in Boston, MA (December 12–13, 2019). If you have not yet registered for this workshop, the program for which is posted at issx.org/2019workshop, please register soon since space is limited due to the size of the auditorium. As I mentioned in the last Newsletter, 2020 will be a ver y busy year for ISSX, since we will be co-hosting two impor tant meetings. The first with the European
Association for Clinical Pharmacology and Therapeutics (EACPT) in Geneva, Switzerland, from June 7–10, 2020 Thomas Baillie, Ph.D. (information is ISSX President. available at www. issxeacpt2020.org), and the second with colleagues from the Japanese Society for the Study of Xenobiotics (JSSX) at the Hilton Waikoloa Village Resor t on the Big Island of Hawaii from October 4–8, 2020. Both meetings feature exciting scientific programs and will be held in ver y attractive locations, so they are cer tain to be well attended! Additionally, by popular demand, we are re-instituting our ISSX webinar series. The first of these, dealing with OATP1B1-mediated drug-drug interactions and delivered Continued on page 10
IN THIS ISSUE 2 3
Book Review
4
Renew Your ISSX Membership for 2020
2019 ISSX Workshop Disposition of Biologics
5
Enroll in the ISSX Mentorship Program
6
15th European ISSX and EACPT Joint Meeting
7
23rd North American ISSX Meeting & 35th JSSX Meeting
8 4th Annual Conference of SSX-India 11 Changes to the ISSX Council 14 Welcome New Members 14 ISSX Focus Groups